Cleared Traditional

K871226 - SYPHILIS SEROLOGICAL REAGENTS

K871226 is the FDA 510(k) clearance for SYPHILIS SEROLOGICAL REAGENTS by New Horizons Diagnostics Co.. It is a Class 2 Microbiology device (product code GMQ) cleared through the Traditional 510(k) pathway after a 62-day FDA review.

K871226 · New Horizons Diagnostics Co. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1987
Decision
62d
Days
Class 2
Risk

K871226 is an FDA 510(k) clearance for the SYPHILIS SEROLOGICAL REAGENTS. Classified as Antigens, Nontreponemal, All (product code GMQ), Class II - Special Controls.

Submitted by New Horizons Diagnostics Co. (Columbia, US). The FDA issued a Cleared decision on May 28, 1987 after a review of 62 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3820 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all New Horizons Diagnostics Co. devices

Submission Details

510(k) Number K871226 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 27, 1987
Decision Date May 28, 1987
Days to Decision 62 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 102d · This submission: 62d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GMQ Antigens, Nontreponemal, All
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3820
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - GMQ Antigens, Nontreponemal, All

All 14
Devices cleared under the same product code (GMQ) and FDA review panel - the closest regulatory comparables to K871226.
ASI Automated ASI RPR Test for Syphilis on the ASI Evolution
K182391 · Arlington Scientific, Inc. (Asi) · Nov 2018
ASI Evolution
K173376 · Arlington Scientific, Inc. (Asi) · Jun 2018
STANBIO SYPHILIS RPR TEST, NO. 1170
K880144 · Stanbio Laboratory · May 1988
AUTOGROUPER 16C SYS AUTOMATED REAG
K834149 · Technicon Instruments Corp. · Mar 1984
TRUST RPR CARD TEST #65144
K832479 · Emd Chemicals, Inc. · Sep 1983
TRUST RPR TITRATION CARD TEST #65145
K832480 · Emd Chemicals, Inc. · Sep 1983